Log In
Print this Print this

Capesaris (GTx-758)

  Manage Alerts
Collapse Summary General Information
Company GTx Inc.
DescriptionOral selective estrogen receptor 1 (ESR1) agonist
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of ActionEstrogen receptor alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat advanced prostate cancer; Treat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today